S-ICD implantation study for heart patients
Part of Heart & circulation clinical trials.
This study looks at implanting a type of ICD (implantable cardioverter-defibrillator) called a subcutaneous ICD, or S-ICD, which goes under the skin instead of in the heart. It is designed to help see how well this works in standard care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled to get an S-ICD implanted
- You are able to understand and agree to the study
- You are not pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is a registry that collects real-world information from people who receive an S-ICD (a small device under the skin) to help doctors learn how these devices perform over time. You may qualify if you already had the implant and can be followed for at least one month.
This trial studies whether implanting a defibrillator (ICD) soon after a heart attack can lower the risk of sudden cardiac death in people with weaker heart pumping and symptoms of heart failure. It compares strategies around defibrillator implantation, aiming to improve safety and outcomes.
This trial tests whether a programmed heart rhythm test can better identify who needs an implanted defibrillator (ICD) soon after a heart attack. It may help prevent dangerous fast heart rhythms (tachyarrhythmias) by guiding who gets an ICD.
This trial tests whether using an MRI to guide the placement of a defibrillator (ICD) helps people with weak hearts. It might offer a more precise way to implant the device.
This study follows people who are scheduled to get a new ICD (a device that helps protect the heart) and asks about their experiences and quality of life. It may help doctors understand what patients feel and how people do after ICD implantation.
This study looks at placing an ICD, a device that can stop dangerous heart rhythms, to help prevent sudden cardiac death. It is for people over 70 with specific heart function and heart failure symptoms.
Hear when a new Sudden Cardiac Death trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.